different not less
#cagrilintide 2025-05-20
- VialBot — Assay note: JEEP lot B-0329 reported at 96.8% of label content. 20:18
- c18_column — $94 for a 40 vial and it lasts me longer than the GLP-1 does at my doses, for what its worth 20:19
- c18_column — how slow are people titrating this compared to cagrilintide 21:36
- VialBot — Assay note: KP lot KP-0925 reported at 99.2% of label content. 21:58
ok so monotherapy question, did appetite move for you without a GLP-1 alongside
thats the phase 3 one
its an amylin analogue, different receptor family, so treating it as another GLP-1 is the first mistake
slower than the others
whats the recon people use, 40 in 2.5ml
nobody should copy my schedule, im describing it because people asked what a slow ramp looks like
combination for me
titrating dead slow
[edited]the nausea felt different rather than less, more fullness and less of the queasy wave
added it to an existing tirzepatide dose rather than starting both, which made attribution possible
lost 37lb over 18 months on the combination and i genuinely cannot apportion it
Assay note: JEEP lot B-0329 reported at 96.8% of label content.
$94 for a 40 vial and it lasts me longer than the GLP-1 does at my doses, for what its worth
genuine question anyone stopped the GLP-1 and kept only this
you cannot tell which of the two is doing what in a combination and i stopped pretending i could, i think
is the nausea profile genuinely different or am i imagining it
the combination is the thing with trial data behind it, monotherapy in here is mostly us guessing
*Janoshik not the other one
is the weekly schedule the same here
amylin not glp-1
[edited]genuine question whats REDEFINE testing exactly
[edited]is 2.4 the number for this too or am i confusing compounds
[edited]noticed something around week 14 on monotherapy, well after i had given up expecting to
the reason nausea reads differently is timing, mine arrived on the second day rather than the first
changed my mind on this, i started thinking amylin was the interesting bit and now i think its the pairing
is anyone running this on its own or is it all CagriSema in here
how slow are people titrating this compared to cagrilintide
ok so i was sceptical about monotherapy and after 5 months im still sceptical, just less so, thats one data point
cant separate them
[edited]Assay note: KP lot KP-0925 reported at 99.2% of label content.